These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Postoperative changes in cognition and cerebrospinal fluid neurodegenerative disease biomarkers. Berger M; Browndyke JN; Cooter Wright M; Nobuhara C; Reese M; Acker L; Bullock WM; Colin BJ; Devinney MJ; Moretti EW; Moul JW; Ohlendorf B; Laskowitz DT; Waligorska T; Shaw LM; Whitson HE; Cohen HJ; Mathew JP; Ann Clin Transl Neurol; 2022 Feb; 9(2):155-170. PubMed ID: 35104057 [TBL] [Abstract][Full Text] [Related]
6. Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer's disease, and neuronal injury in humans: a cohort study. Pikwer A; Castegren M; Namdar S; Blennow K; Zetterberg H; Mattsson N J Neuroinflammation; 2017 Sep; 14(1):193. PubMed ID: 28962579 [TBL] [Abstract][Full Text] [Related]
7. Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults. Popp J; Oikonomidi A; Tautvydaitė D; Dayon L; Bacher M; Migliavacca E; Henry H; Kirkland R; Severin I; Wojcik J; Bowman GL Brain Behav Immun; 2017 May; 62():203-211. PubMed ID: 28161476 [TBL] [Abstract][Full Text] [Related]
8. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Ritchie C; Smailagic N; Noel-Storr AH; Ukoumunne O; Ladds EC; Martin S Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010803. PubMed ID: 28328043 [TBL] [Abstract][Full Text] [Related]
9. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model. Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W; J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262 [TBL] [Abstract][Full Text] [Related]
10. Non-neurological surgery and cerebrospinal fluid biomarkers for neuronal and astroglial integrity. Anckarsäter R; Anckarsäter H; Bromander S; Blennow K; Wass C; Zetterberg H J Neural Transm (Vienna); 2014 Jun; 121(6):649-53. PubMed ID: 24420082 [TBL] [Abstract][Full Text] [Related]
11. Associations of Alcohol Consumption with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study. Wang ZT; Li KY; Tan CC; Xu W; Shen XN; Cao XP; Wang P; Bi YL; Dong Q; Tan L; Yu JT J Alzheimers Dis; 2021; 82(3):1045-1054. PubMed ID: 34151793 [TBL] [Abstract][Full Text] [Related]
12. Effects of anesthetic isoflurane and desflurane on human cerebrospinal fluid Aβ and τ level. Zhang B; Tian M; Zheng H; Zhen Y; Yue Y; Li T; Li S; Marcantonio ER; Xie Z Anesthesiology; 2013 Jul; 119(1):52-60. PubMed ID: 23438677 [TBL] [Abstract][Full Text] [Related]
13. Associations of Green Tea Consumption and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study. Ma YH; Wu JH; Xu W; Shen XN; Wang HF; Hou XH; Cao XP; Bi YL; Dong Q; Feng L; Tan L; Yu JT J Alzheimers Dis; 2020; 77(1):411-421. PubMed ID: 32804140 [TBL] [Abstract][Full Text] [Related]
14. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study. Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM; J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495 [TBL] [Abstract][Full Text] [Related]
16. Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker. Gleason CE; Norton D; Anderson ED; Wahoske M; Washington DT; Umucu E; Koscik RL; Dowling NM; Johnson SC; Carlsson CM; Asthana S; J Alzheimers Dis; 2018; 61(1):79-89. PubMed ID: 29125485 [TBL] [Abstract][Full Text] [Related]
17. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database. Ben Bouallègue F; Mariano-Goulart D; Payoux P; Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967 [TBL] [Abstract][Full Text] [Related]
18. Tau and Amyloid-β Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment. Malpas CB; Saling MM; Velakoulis D; Desmond P; O'Brien TJ; J Alzheimers Dis; 2015; 47(4):965-75. PubMed ID: 26401775 [TBL] [Abstract][Full Text] [Related]
19. A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium. Somers C; Struyfs H; Goossens J; Niemantsverdriet E; Luyckx J; De Roeck N; De Roeck E; De Vil B; Cras P; Martin JJ; De Deyn PP; Bjerke M; Engelborghs S J Alzheimers Dis; 2016 Aug; 54(1):383-95. PubMed ID: 27567807 [TBL] [Abstract][Full Text] [Related]
20. The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. Molinuevo JL; Blennow K; Dubois B; Engelborghs S; Lewczuk P; Perret-Liaudet A; Teunissen CE; Parnetti L Alzheimers Dement; 2014 Nov; 10(6):808-17. PubMed ID: 25150736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]